Xenical + behavioral intervention
Drug120 mg TID; Behavioral weight loss in Spanish
Other names: Xenical
NCT Number: NCT00516919
This is a research study designed to examine the effectiveness of an obesity medication (orlistat) given in addition to behavioral weight loss therapy. Participants will be obese monolingual (Spanish-speaking only) men and women.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Phase 4
Hispanic Clinic of the Connecticut Mental Health Center, New Haven, Connecticut, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
120 mg TID; Behavioral weight loss in Spanish
Other names: Xenical
Behavioral weight loss treatment in Spanish Placebo TID
Time frame: 4 months and 6 month follow-up
Body Mass Index (BMI)
Yale University
Other
Controlled Trial of Orlistat With Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06349460
Binge Eating, Body Weight
Chicago, Illinois, United States
View Trial DetailsNCT02977403
Behavior, Behavior, Animal
Bethesda, Maryland, United States
View Trial DetailsNCT04771455
Binge Eating, Body Weight
Chicago, Illinois, United States
View Trial DetailsNCT00537810
Binge Eating, Body Weight
New Haven, Connecticut, United States
View Trial Details